Acute Impairment of Mitochondrial Trafficking by β-Amyloid Peptides in Hippocampal Neurons
暂无分享,去创建一个
[1] F. Saatcioglu,et al. Inhibition of apoptosis in prostate cancer cells by androgens is mediated through downregulation of c-Jun N-terminal kinase activation. , 2008, Neoplasia.
[2] M. Tabaton,et al. The various aggregation states of beta-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression. , 2006, Free radical biology & medicine.
[3] I. Reynolds,et al. Mitochondrial Trafficking to Synapses in Cultured Primary Cortical Neurons , 2006, The Journal of Neuroscience.
[4] G. Perry,et al. Alzheimer's disease: an intracellular movement disorder? , 2005, Trends in molecular medicine.
[5] E. Masliah,et al. Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.
[6] Yasunori Hayashi,et al. The Importance of Dendritic Mitochondria in the Morphogenesis and Plasticity of Spines and Synapses , 2004, Cell.
[7] M. Duchen,et al. Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in culture. , 2004, Biochimica et biophysica acta.
[8] C. Finch,et al. Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers , 2004, The Journal of Neuroscience.
[9] B. Eickholt,et al. A molecular cell biology of lithium. , 2004, Biochemical Society transactions.
[10] R. Anwyl,et al. Mechanisms of the inhibitory effects of amyloid β-protein on synaptic plasticity , 2004, Experimental Gerontology.
[11] M. Mattson. Pathways towards and away from Alzheimer's disease , 2004, Nature.
[12] S. Lipton,et al. Molecular pathways to neurodegeneration , 2004, Nature Medicine.
[13] C. Ross,et al. Protein aggregation and neurodegenerative disease , 2004, Nature Medicine.
[14] Michael P. Sheetz,et al. Axonal mitochondrial transport and potential are correlated , 2004, Journal of Cell Science.
[15] M. Duchen,et al. β-Amyloid Peptides Induce Mitochondrial Dysfunction and Oxidative Stress in Astrocytes and Death of Neurons through Activation of NADPH Oxidase , 2004, The Journal of Neuroscience.
[16] D. Selkoe. Folding proteins in fatal ways , 2003, Nature.
[17] B. Winblad,et al. Apolipoprotein E and β‐amyloid (1–42) regulation of glycogen synthase kinase‐3β , 2003 .
[18] Anne Eckert,et al. Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. , 2003, Biochemical pharmacology.
[19] T. Kawakami,et al. Glutamate and Amyloid β-Protein Rapidly Inhibit Fast Axonal Transport in Cultured Rat Hippocampal Neurons by Different Mechanisms , 2003, The Journal of Neuroscience.
[20] Mark P Mattson,et al. Neuronal and glial calcium signaling in Alzheimer's disease. , 2003, Cell calcium.
[21] M. Duchen,et al. Changes in Intracellular Calcium and Glutathione in Astrocytes as the Primary Mechanism of Amyloid Neurotoxicity , 2003, The Journal of Neuroscience.
[22] J. Waschek. Multiple Actions of Pituitary Adenylyl Cyclase Activating Peptide in Nervous System Development and Regeneration , 2002, Developmental Neuroscience.
[23] Hai Lin,et al. Imaging real-time aggregation of amyloid beta protein (1–42) by atomic force microscopy , 2002, Peptides.
[24] H. Orr,et al. The GSK3β signaling cascade and neurodegenerative disease , 2002, Current Opinion in Neurobiology.
[25] G. Perry,et al. Amyloid-β, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs? , 2002, Neurochemistry International.
[26] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[27] H. Eldar-Finkelman. Glycogen synthase kinase 3: an emerging therapeutic target. , 2002, Trends in molecular medicine.
[28] Nancy Ratner,et al. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin‐based motility , 2002, The EMBO journal.
[29] Brett Chromy,et al. Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus , 2002, Brain Research.
[30] R. Jope,et al. The multifaceted roles of glycogen synthase kinase 3β in cellular signaling , 2001, Progress in Neurobiology.
[31] L. Greene,et al. β‐Amyloid‐induced neuronal apoptosis requires c‐Jun N‐terminal kinase activation , 2001, Journal of neurochemistry.
[32] D. Choi,et al. Assessment of Cell Viability in Primary Neuronal Cultures , 2000, Current protocols in neuroscience.
[33] J W Yates,et al. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. , 2000, Chemistry & biology.
[34] R. Lal,et al. Fresh and globular amyloid β protein (1–42) induces rapid cellular degeneration: evidence for AβP channel‐mediated cellular toxicity , 2000 .
[35] H. Manji,et al. The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3 , 2000, Journal of neurochemistry.
[36] M. Kiebler,et al. Fast, convenient, and effective method to transiently transfect primary hippocampal neurons , 1999, Journal of neuroscience research.
[37] A. Bacci,et al. Synaptic and intrinsic mechanisms shape synchronous oscillations in hippocampal neurons in culture , 1999, The European journal of neuroscience.
[38] A. Takashima,et al. Activation of tau protein kinase I/glycogen synthase kinase-3β by amyloid β peptide (25–35) enhances phosphorylation of tau in hippocampal neurons , 1998, Neuroscience Research.
[39] J. Jordán,et al. Role of Calpain‐ and Interleukin‐1β Converting Enzyme‐Like Proteases in the β‐Amyloid‐Induced Death of Rat Hippocampal Neurons in Culture , 1997 .
[40] B. Seilheimer,et al. A Biotechnological Method Provides Access to Aggregation Competent Monomeric Alzheimer's 1–42 Residue Amyloid Peptide , 1995, Bio/Technology.
[41] C. Cotman,et al. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[42] C. Cotman,et al. Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity , 1995 .
[43] W. Maxwell Cowan,et al. Rat hippocampal neurons in dispersed cell culture , 1977, Brain Research.
[44] R. Anwyl,et al. Mechanisms of the inhibitory effects of amyloid beta-protein on synaptic plasticity. , 2004, Experimental gerontology.
[45] C. Finch,et al. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[46] B. Winblad,et al. Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta. , 2003, Journal of neurochemistry.
[47] W Blaine Stine,et al. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. , 2002, Brain research.
[48] H. Orr,et al. The GSK3 beta signaling cascade and neurodegenerative disease. , 2002, Current opinion in neurobiology.
[49] F. Leuven,et al. Axonal transport, tau protein, and neurodegeneration in Alzheimer’s disease , 2002, NeuroMolecular Medicine.
[50] H. Lin,et al. Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity. , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[51] A. Takashima,et al. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. , 1998, Neuroscience research.
[52] R. Miller,et al. Role of calpain- and interleukin-1 beta converting enzyme-like proteases in the beta-amyloid-induced death of rat hippocampal neurons in culture. , 1997, Journal of neurochemistry.
[53] L. B. Chen,et al. Mitochondrial membrane potential monitored by JC-1 dye. , 1995, Methods in enzymology.
[54] C. Cotman,et al. Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. , 1995, Journal of neurochemistry.